At the request of the FDA, the vaccine makers are expanding their trials with young children, seeking to better detect very rare heart issues.
Coronavirus cases are on the rise across the country as the highly contagious delta variant spreads, with cases and deaths overwhelmingly among people who are unvaccinated.
As schools are set to reopen for in-person learning in the fall, the issue of vaccinating students is top of mind for parents, teachers and school staff. . A Pfizer spokesperson told HuffPost that the company has not provided any further updates to its vaccine trial timelines for children., expects to seek emergency authorization in late 2021 or early 2022, a spokesperson told the Times.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Pfizer And Moderna To Expand Studies Of Vaccines In 5- To 11-Year-OldsAt the request of the FDA, the vaccine makers are expanding their trials with young children, seeking to better detect very rare heart issues.
Leer más »
WSJ News Exclusive | Covid-19 Immunity Wanes, but Third Shot Still Rarely Needed, BioNTech CEO SaysCovid-19 immunity wanes in people fully vaccinated with the Pfizer-BioNTech shot, but most still won’t need a third dose, the CEO of BioNTech said
Leer más »
Covid-19 Vaccine Pioneer BioNTech Plans to Make New Malaria and Tuberculosis Shots in AfricaBioNTech said it would invest some of the profits from the Covid-19 vaccine it markets with Pfizer into developing shots for malaria and tuberculosis in Africa, part of the company’s plan to establish a production hub for innovative medicines
Leer más »
FDA Grants Priority Review Status to Pfizer VaccineThe U.S. Food and Drug Administration has granted priority review status to the Pfizer/BioNTech coronavirus vaccine for people 16 and up.
Leer más »
Mixed AstraZeneca-Pfizer shot boosts COVID antibody level - studyA mixed vaccination of first AstraZeneca (AZN.L) and then a Pfizer (PFE.N) COVID-19 shot boosted neutralizing antibody levels by six times compared with two AstraZeneca doses, a study from South Korea showed.
Leer más »
Moderna to expand size of Covid-19 vaccine trial for younger children, expects to seek EUA in late 2021 or early 2022Moderna will expand the size of its Covid-19 vaccine trial in younger children, the company said Monday, and will not seek emergency use authorization for the vaccine in that age group until later this year or early next year.
Leer más »